KR102447510B1 - 카나비스 조성물 - Google Patents

카나비스 조성물 Download PDF

Info

Publication number
KR102447510B1
KR102447510B1 KR1020217033707A KR20217033707A KR102447510B1 KR 102447510 B1 KR102447510 B1 KR 102447510B1 KR 1020217033707 A KR1020217033707 A KR 1020217033707A KR 20217033707 A KR20217033707 A KR 20217033707A KR 102447510 B1 KR102447510 B1 KR 102447510B1
Authority
KR
South Korea
Prior art keywords
weight
terpene
cannabis
amount
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217033707A
Other languages
English (en)
Korean (ko)
Other versions
KR20210129747A (ko
Inventor
해리 카렐리스
마라 고든
스튜어트 스미스
스튜어트 워셔
Original Assignee
젤리라 테라퓨틱스 오퍼레이션즈 피티와이 엘티디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65524553&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR102447510(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2017901222A external-priority patent/AU2017901222A0/en
Application filed by 젤리라 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 filed Critical 젤리라 테라퓨틱스 오퍼레이션즈 피티와이 엘티디
Priority to KR1020227032758A priority Critical patent/KR20220132674A/ko
Publication of KR20210129747A publication Critical patent/KR20210129747A/ko
Application granted granted Critical
Publication of KR102447510B1 publication Critical patent/KR102447510B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020217033707A 2016-08-03 2017-08-03 카나비스 조성물 Active KR102447510B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020227032758A KR20220132674A (ko) 2016-08-03 2017-08-03 카나비스 조성물

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201662370299P 2016-08-03 2016-08-03
US62/370,299 2016-08-03
AU2017901222A AU2017901222A0 (en) 2017-04-04 Cannabis composition
AU2017901222 2017-04-04
AU2017902065A AU2017902065A0 (en) 2017-05-31 Cannabis composition
AU2017902065 2017-05-31
KR1020197005323A KR20190034576A (ko) 2016-08-03 2017-08-03 카나비스 조성물
PCT/AU2017/050817 WO2018023166A1 (en) 2016-08-03 2017-08-03 Cannabis composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020197005323A Division KR20190034576A (ko) 2016-08-03 2017-08-03 카나비스 조성물

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020227032758A Division KR20220132674A (ko) 2016-08-03 2017-08-03 카나비스 조성물

Publications (2)

Publication Number Publication Date
KR20210129747A KR20210129747A (ko) 2021-10-28
KR102447510B1 true KR102447510B1 (ko) 2022-09-27

Family

ID=65524553

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020217033707A Active KR102447510B1 (ko) 2016-08-03 2017-08-03 카나비스 조성물
KR1020227032758A Ceased KR20220132674A (ko) 2016-08-03 2017-08-03 카나비스 조성물
KR1020197005323A Ceased KR20190034576A (ko) 2016-08-03 2017-08-03 카나비스 조성물

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020227032758A Ceased KR20220132674A (ko) 2016-08-03 2017-08-03 카나비스 조성물
KR1020197005323A Ceased KR20190034576A (ko) 2016-08-03 2017-08-03 카나비스 조성물

Country Status (15)

Country Link
US (2) US11304925B1 (https=)
EP (1) EP3493800A4 (https=)
JP (2) JP2019526541A (https=)
KR (3) KR102447510B1 (https=)
CN (1) CN109789123A (https=)
AU (4) AU2017305103B2 (https=)
BR (1) BR112019001794A2 (https=)
CA (1) CA3031300A1 (https=)
CL (1) CL2019000266A1 (https=)
CO (1) CO2019001043A2 (https=)
IL (1) IL264458B (https=)
MX (1) MX386086B (https=)
PE (2) PE20230607A1 (https=)
SG (1) SG11201900501RA (https=)
WO (1) WO2018023166A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3031810A1 (en) 2016-08-03 2018-02-08 Zelda Therapeutics Operations Pty Ltd Cannabis composition
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
AU2018100837B4 (en) 2017-06-19 2019-02-21 Zelira Therapeutics Operations Pty Ltd Sleep Disorder Compositions and Treatments Thereof
CA3103178A1 (en) * 2017-06-27 2019-01-03 Enviro BioMedical Laboratories Inc. Blended cannabis compounds and methods of making the same
SG11202002169TA (en) * 2017-09-15 2020-04-29 Zelda Therapeutics Operations Pty Ltd Composition and method for treating autism
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
CN112969452A (zh) * 2018-04-09 2021-06-15 艾乐文特科学公司 用于治疗动物疼痛的大麻提取物
WO2019227167A1 (en) * 2018-06-01 2019-12-05 The University Of Sydney Compositions and treatments
US11946016B2 (en) 2018-06-14 2024-04-02 Biosoma B.V. Process for the extraction of oil-soluble components from plant material
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
WO2020084423A1 (en) * 2018-10-24 2020-04-30 Radient Technologies Innovations Inc. Extraction-based contract execution
CA3123773A1 (en) * 2018-12-12 2020-06-18 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Compositions and methods for the treatment of cutaneous t cell lymphoma (ctcl)
NL2022615B1 (en) * 2019-02-21 2020-08-31 Patrick Alexander Unger Pharmaceutical composition comprising tetrahydrocannabivarin for the prevention and treatment of overweight
FI3920891T3 (fi) * 2019-04-17 2024-03-19 Nordiccan As Nopeasti hajoavat kannabinoiditabletit
CA3154295A1 (en) * 2019-10-09 2021-04-15 Michael Foster DAVIS Aerosolisable material
CN118161552A (zh) * 2019-12-19 2024-06-11 史蒂文·罗斯斯坦 富含多酚化合物的提取物以及相关方法
CN115605289A (zh) * 2020-04-29 2023-01-13 利加尔有限合伙公司（Nz） 印迹聚合物及其使用方法
EP4146193A4 (en) * 2020-05-04 2024-05-29 Agronomed Management, LLC Topical anti-inflammatory cannabinoid compositions
WO2021248207A1 (en) * 2020-06-12 2021-12-16 Zelira Therapeutics Operations Pty Ltd Composition and method for treating chronic pain
WO2022191551A1 (ko) * 2021-03-08 2022-09-15 주식회사 엘지생활건강 칸나비게롤을 포함하는 조성물
IL307444A (en) * 2021-04-05 2023-12-01 The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo Preparations and methods for the treatment of cancer
US12440454B2 (en) 2022-02-01 2025-10-14 Portland Technology Holdings Llc Pharmaceutical compositions containing hemp extract for administration to felines and related methods
WO2025231524A1 (en) * 2024-05-08 2025-11-13 Heyday RX Pty Ltd Cannabinoid compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011110866A1 (en) * 2010-03-12 2011-09-15 Gw Pharma Limited Phytocannabinoids in the treatment of cancer
US20140271940A1 (en) 2013-03-14 2014-09-18 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
WO2016064987A1 (en) * 2014-10-21 2016-04-28 United Cannabis Corp. Cannabis extracts and methods of preparing and using same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10051427C1 (de) * 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
GB2418612A (en) 2004-10-01 2006-04-05 Gw Pharma Ltd Inhibition of tumour cell migration with cannabinoids
US8628796B2 (en) 2004-12-09 2014-01-14 Insys Therapeutics, Inc. Room-temperature stable dronabinol formulations
WO2007032962A2 (en) 2005-09-09 2007-03-22 University Of Kentucky Compositions and methods for intranasal delivery of tricyclic cannabinoids
US8980940B2 (en) * 2006-11-10 2015-03-17 Johnson Matthey Public Limited Company Stable cannabinoid compositions and methods for making and storing them
GB201117956D0 (en) * 2011-10-18 2011-11-30 Otsuka Pharma Co Ltd Phytocannabinoids for use in the treatment of breast cancer
AU2013257322A1 (en) 2012-05-03 2014-11-20 Echo Pharmaceuticals B.V. Cannabis plant isolate comprising delta9-tetrahydrocannabinol and a method for preparing such an isolate
US9095554B2 (en) 2013-03-15 2015-08-04 Biotech Institute LLC Breeding, production, processing and use of specialty cannabis
LT3062606T (lt) 2013-10-29 2019-07-10 Biotech Institute, Llc Specializuotų kanapių selekcija, gamyba, perdirbimas ir panaudojimas
US9044390B1 (en) 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
US10610512B2 (en) 2014-06-26 2020-04-07 Island Breeze Systems Ca, Llc MDI related products and methods of use
CA2996626A1 (en) * 2014-08-25 2016-03-03 Janing Holding Aps Device with compositions for delivery to the lungs, the oral mucosa and the brain
MX385464B (es) 2014-12-12 2025-03-18 Ojai Energetics Pbc Composiciones microencapsuladas de cannabinoides
WO2016105514A1 (en) * 2014-12-23 2016-06-30 Biotech Institute, Llc A reliable and robust method for the analysis of cannabinoids and terpenes in cannabis
IL253664B (en) 2015-01-31 2022-09-01 Constance Therapeutics Inc Production method for extracting oil from cannabis and preparations
CA3031810A1 (en) 2016-08-03 2018-02-08 Zelda Therapeutics Operations Pty Ltd Cannabis composition
CA3031811A1 (en) 2016-08-03 2018-02-08 Zelda Therapeutics Operations Pty Ltd Cannabis composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011110866A1 (en) * 2010-03-12 2011-09-15 Gw Pharma Limited Phytocannabinoids in the treatment of cancer
US20140271940A1 (en) 2013-03-14 2014-09-18 Sc Laboratories, Inc. Bioactive concentrates and uses thereof
WO2016064987A1 (en) * 2014-10-21 2016-04-28 United Cannabis Corp. Cannabis extracts and methods of preparing and using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
British journal of pharmacology, 2011, 163(7), pp. 1344-1364*

Also Published As

Publication number Publication date
US20220202767A1 (en) 2022-06-30
MX386086B (es) 2025-03-18
AU2018100920A4 (en) 2018-08-02
SG11201900501RA (en) 2019-02-27
AU2021205115B2 (en) 2023-06-15
WO2018023166A1 (en) 2018-02-08
BR112019001794A2 (pt) 2019-05-07
AU2017305103A1 (en) 2018-07-05
KR20220132674A (ko) 2022-09-30
JP2019526541A (ja) 2019-09-19
US11304925B1 (en) 2022-04-19
AU2021205115A1 (en) 2021-08-12
AU2019203529B2 (en) 2021-04-29
MX2019001286A (es) 2019-06-13
IL264458B (en) 2021-06-30
CN109789123A (zh) 2019-05-21
CA3031300A1 (en) 2018-02-08
CL2019000266A1 (es) 2019-10-04
KR20190034576A (ko) 2019-04-02
AU2017305103B2 (en) 2019-02-21
JP7139559B2 (ja) 2022-09-21
IL264458A (en) 2019-02-28
JP2021054836A (ja) 2021-04-08
KR20210129747A (ko) 2021-10-28
PE20230607A1 (es) 2023-04-13
EP3493800A4 (en) 2020-04-08
PE20200677A1 (es) 2020-06-11
EP3493800A1 (en) 2019-06-12
AU2019203529A1 (en) 2019-06-06
CO2019001043A2 (es) 2020-06-19
AU2018100920B4 (en) 2019-02-07
NZ750272A (en) 2021-09-24

Similar Documents

Publication Publication Date Title
KR102447510B1 (ko) 카나비스 조성물
US11779562B2 (en) Cannabis composition
KR20210071940A (ko) Ptsd 및/또는 불안을 치료하기 위한 칸나비노이드 조성물 및 방법
NZ750272B2 (en) Cannabis composition

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20211019

Application number text: 1020197005323

Filing date: 20190222

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20211116

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220107

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20220803

A107 Divisional application of patent
GRNT Written decision to grant
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20220921

Application number text: 1020197005323

Filing date: 20190222

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220921

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220922

End annual number: 3

Start annual number: 1

PG1601 Publication of registration